Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
  89R13578 MPF-F     By: Villalobos H.B. No. 4441       A BILL TO BE ENTITLED   AN ACT   relating to the administration of topical ophthalmic medications at   certain health care facilities.          BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:          SECTION 1.  This Act may be cited as the Topical Ophthalmic   Medication Waste Reduction Act.          SECTION 2.  Subtitle A, Title 6, Health and Safety Code, is   amended by adding Chapter 446 to read as follows:   CHAPTER 446. ADMINISTRATION OF TOPICAL OPHTHALMIC MEDICATION AT   CERTAIN HEALTH CARE FACILITY           Sec. 446.001.  DEFINITIONS. In this chapter:                 (1)  "Health care facility" means:                       (A)  a hospital licensed under Chapter 241; or                       (B)     an ambulatory surgical center licensed under   Chapter 243.                 (2)     "Topical ophthalmic medication" means a   prescription drug for ophthalmic use in drop or ointment form,   including antibiotic, anti-inflammation, dilation, or glaucoma   medication.           Sec.   446.002.     RELEASE OF UNUSED MEDICATION. (a) A health   care facility shall offer to a patient on discharge from the   facility following a surgical procedure performed on the patient   any unused portion of a topical ophthalmic medication administered   to the patient if:                 (1)     a health care professional at the facility ordered   the medication for the patient not more than 24 hours before the   surgical procedure; and                 (2)     the patient's treating physician prescribes the   medication to the patient for continuing treatment.           (b)     A health care facility that provides to a patient a   topical ophthalmic medication under Subsection (a) shall ensure the   patient is counseled on the medication's proper use and   administration.           Sec.   446.003.     REUSE OF UNUSED MEDICATION. A health care   facility that provides to a patient an unlabeled topical ophthalmic   medication held by the facility on reserve or obtained by the   facility from a prescription drug dispensing system may provide the   unused portion of the medication to other patients receiving   treatment at the facility for a period not to exceed 24 hours after   the medication's initial provision.          SECTION 3.  This Act takes effect September 1, 2025.